The clinically used poly(ADP-ribose) polymerase (PARP) inhibitor olaparib improves organ function, suppresses inflammatory responses and accelerates wound healing in a murine model of third-degree burn injury.
about
The clinically used poly(ADP-ribose) polymerase (PARP) inhibitor olaparib improves organ function, suppresses inflammatory responses and accelerates wound healing in a murine model of third-degree burn injury.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
The clinically used poly(ADP-r ...... l of third-degree burn injury.
@en
type
label
The clinically used poly(ADP-r ...... l of third-degree burn injury.
@en
prefLabel
The clinically used poly(ADP-r ...... l of third-degree burn injury.
@en
P2093
P2860
P356
P1476
The clinically used PARP inhib ...... el of third-degree burn injury
@en
P2093
Akbar Ahmad
David N Herndon
Gabor Olah
P2860
P304
P356
10.1111/BPH.13735
P407
P50
P577
2017-03-05T00:00:00Z